• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

LensAR Inc.

FDA clears Lensar Ally cataract treatment system

June 13, 2022 By Sean Whooley

Lensar (Nasdaq:LNSR) announced today that it received FDA 510(k) clearance for its next-generation Ally system. Orlando, Florida–based Lensar designed the Ally adaptive cataract treatment system to enable cataract surgeons to complete the femtosecond-laser-assisted cataract (FLACS) procedure seamlessly in a single, sterile environment. According to a news release, the company intends to deliver the first Ally […]

Filed Under: 510(k), Featured, Food & Drug Administration (FDA), Health Technology, News Well, Optical/Ophthalmic, Regulatory/Compliance, Surgical Tagged With: FDA, LensAR Inc.

FDA clears presbyopia treatment indications for Lensar’s Laser System

April 11, 2018 By Fink Densford

Lensar said today it won FDA 510(k) clearance for its Lensar Laser System with Streamline IV designed to create corneal pockets and flaps used in presbyopia treatments. With the new clearance, the Lensar Laser System is now indicated for use in procedures to implant presbyopic inlay devices, the Orlando, Fla.-based company said. The newly cleared […]

Filed Under: 510(k), Food & Drug Administration (FDA), Optical/Ophthalmic, Regulatory/Compliance Tagged With: LensAR Inc.

7 medtech stories we missed this week: Nov. 17, 2017

November 17, 2017 By Danielle Kirsh

From Skyline Medical’s joint venture to Lensar receiving FDA clearance and CE Mark, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Skyline Medical launches JV deal with Helomics Skyline Medical announced in a Nov. 15 press release that it has signed a joint venture agreement with Helomics. […]

Filed Under: 510(k), Diagnostics, Digital Health, Food & Drug Administration (FDA), Neurological, Neuromodulation/Neurostimulation, Regenerative Medicine, Regulatory/Compliance, Research & Development Tagged With: Helomics, InnerScope, iReliev, LensAR Inc., MedTech, Mevion Medical Systems, Mortise Medical, Nexstim, Skyline Medical

7 medtech stories we missed this week: May 12, 2017

May 12, 2017 By Danielle Kirsh

From Bioness’s new distribution deal to InBrace’s launch of new braces technology, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Obalon receives approval to commercialize in Middle East Obalon Therapeutics announced in a May 11 press release that it has received regulatory approvals in select Middle East […]

Filed Under: Business/Financial News, Patient Monitoring, Regulatory/Compliance, Research & Development, Surgical Tagged With: Bioness Inc., InBrace, LensAR Inc., MedTech, Obalon Therapeutics, Ottobock, SRS Medical, Teleon Surgical, ZipLine Medical

Lensar files for Chapter 11 bankruptcy

December 19, 2016 By Sarah Faulkner

Lensar Inc. today filed for Chapter 11 bankruptcy protection, saying it needs to reduce its debt and strengthen its balance sheet and platform for future growth. The Orlando, Fl.-based company was supported by its senior secured lender, PDL BioParhma Inc. In December 2015, healthcare and social commerce company Alphaeon bought the laser cataract treatment company for […]

Filed Under: Legal News, Optical/Ophthalmic, Wall Street Beat Tagged With: LensAR Inc.

Alphaeon closes $59m Lensar buy

December 17, 2015 By Fink Densford

Healthcare and social commerce company Alphaeon said today it closed its buy of laser cataract treatment company Lensar for $59 million. Terms of the deal were not disclosed. Lensar develops and manufactures Femtosecond Lasers Systems designed specifically for refractive cataract surgery, Irvine, Calif.-based Alphaeon said. “We are pleased to have closed the acquisition of Lensar. […]

Filed Under: Business/Financial News, Optical/Ophthalmic Tagged With: Alphaeon, LensAR Inc.

Alphaeon to pick up Lensar

November 19, 2015 By Fink Densford

Healthcare-focused social commerce company Alphaeon said Monday it inked an agreement to acquire all of the assets of laser cataract treatment company Lensar for $59 million. Lensar develops and manufactures Femtosecond Lasers Systems designed specifically for refractive cataract surgery, the company said. “Lensar has advanced the self-pay category of precision refractive surgery both for ophthalmologists […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Optical/Ophthalmic Tagged With: Alphaeon, LensAR Inc.

Allergan CEO Pyott steps down from Edwards Lifesciences board | Personnel Moves

October 7, 2014 By Brad Perriello Leave a Comment

Allergan CEO Pyott steps down from Edwards Lifesciences board | Personnel Moves


Filed Under: News Well Tagged With: Acelity, Allergan, Bio-Rad, Boston Scientific, Edwards Lifesciences, LensAR Inc., LifeCell Corp., Personnel Moves, Polaris Industries, Premier Inc., Sensory Medical, SiBone, STAAR Surgical Co, Thoratec Corp.

LensAR raises $8M for laser eye surgery

August 4, 2014 By Arezu Sarvestani

LensAR raises $8M for laser eye surgery

Opthalmology devices maker LensAR secured $8 million in equity funding, according to an SEC filing dated July 31, 2014.

Filed Under: Funding Roundup, News Well, Optical/Ophthalmic, Surgical Tagged With: Laser/Light-based Devices, LensAR Inc.

LensAR closes $10M equity funding round

January 9, 2014 By Arezu Sarvestani Leave a Comment

LensAR closes $10M equity funding round

Orlando, Fla.-based cataract surgery technology company LensAR closed an equity funding round with $10 million raised from 14 investors, regulatory documents show.

The fundraising effort, launched in December, was closed yesterday and use of the proceeds was not described, outside of an estimated $370,000 listed in payments to individuals listed as "executive officers, directors or promoters" of the company.

Filed Under: Funding Roundup, News Well, Optical/Ophthalmic Tagged With: Laser/Light-based Devices, LensAR Inc.

LensAR launches U.K. clinical trial of laser-based eye surgery

November 19, 2013 By Arezu Sarvestani Leave a Comment

LensAR launches U.K. clinical trial of laser-based eye surgery

Orlando, Fla.-based LensAR Inc. announced the launch of a new U.K. clinical trial, evaluating the company’s laser-based lens softening system in treatment of patients with presbyopia.

The study begins with enrollment of the 1st 30 patients and will expand to more sites by the end of the year, LensAR said.

Filed Under: News Well, Optical/Ophthalmic Tagged With: Clinical Trials, Laser/Light-based Devices, LensAR Inc.

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS